(Press-News.org) WHITEHOUSE STATION, N.J., June 14, 2014 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc analysis showing that patients with type 2 diabetes having treatment intensified with insulin glargine therapy while also being treated with JANUVIA® (sitagliptin) 100 mg once-daily had a lower incidence of nighttime (nocturnal) hypoglycemia compared to patients also receiving placebo. Results were presented at the American Diabetes Association 74th Scientific Sessions.
"Type 2 diabetes is a progressive disease, so that over time many patients need to add insulin to their treatment regimens to maintain blood sugar control," said Peter Stein, M.D., vice president, Clinical Research for diabetes and endocrinology, Merck Research Laboratories. "Insulin therapy can lead to episodes of hypoglycemia that can occur either during the day or overnight while the patient is asleep. Hypoglycemia is troubling to both the patient and to the physician, so treatment approaches that can potentially lower the occurrence of hypoglycemia—overall or overnight—may be important."
JANUVIA is indicated, as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus. JANUVIA should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. JANUVIA has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk of developing pancreatitis while taking JANUVIA. JANUVIA is contraindicated in patients with a history of a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema.
Results of the original study:
The original clinical trial, "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin," was conducted over 24 weeks in 660 insulin-treated patients, randomized to the addition of either JANUVIA (sitagliptin) 100 mg once-daily (n=329) or placebo (n=329) to their insulin regimen. Starting two weeks after randomization, patients were to increase their dose of insulin every three days to reach a targeted fasting blood sugar level of 72-100 mg/dL. After 24 weeks, patients randomized to JANUVIA received less additional insulin compared to patients randomized to placebo.
The study also found that patients in the group randomized to JANUVIA had better blood sugar control after 24 weeks with a significantly lower incidence of hypoglycemia. The group randomized to JANUVIA had an A1C [1] reduction (-1.31% LS mean A1C reduction from a baseline of 8.66%) that was significantly greater than the reduction in the group randomized to placebo (-0.87% LS mean reduction from a baseline of 8.81%; difference between groups p END
New post-hoc analysis shows patients with type 2 diabetes undergoing intensification of insulin therapy experienced less nighttime hypoglycemia while being treated with Januvia (Sitagliptin) compared
2014-06-14
ELSE PRESS RELEASES FROM THIS DATE:
Improving diet quality reduces risk for type 2 diabetes
2014-06-14
June 14, 2014 (San Francisco) – Improving the overall quality of one's diet helps to prevent type 2 diabetes, independent of other lifestyle changes, according to a study presented at the American Diabetes Association's 74th Scientific Sessions®.
The study, by researchers at the Harvard School of Public Health, found that those who improved their diet quality index scores by 10 percent over four years – by eating more whole grains, fruits and vegetables, and less sweetened beverages and saturated fats, for example – reduced their risk for type 2 diabetes by about 20 percent, ...
New theory of diabetic complications' origin suggests need for new therapeutic approach
2014-06-14
SAN DIEGO, CA (June 14, 2014): Use of anti-oxidants may be ineffective or even contribute to kidney disease and other complications of diabetes, rather than helping to treat such health problems. That conclusion, based on growing unexpected findings that stimulating mitochondrial function and superoxide production results in improved markers of renal, cardiovascular and nerve dysfunction, was presented this week in a "State-of-the-Art Lecture" at the 74th Scientific Sessions of the American Diabetes Association.
"Scientists have long hypothesized that oxidative stress ...
Research suggests benefits of canola oil for people with Type 2 diabetes
2014-06-14
TORONTO, June 14, 2014—Canola is Canada's oil and new research from St. Michael's Hospital suggests it should also be one of the oils of choice for people with Type 2 diabetes.
Dr. David Jenkins, head of the hospital's Clinical Nutrition and Risk Factor Modification Centre, compared people with Type 2 diabetes who ate either a low glycemic index diet that included bread made with canola oil, or a whole wheat diet known to reduce the risk of cardiovascular disease.
His study, published today (Saturday, June 14) in the journal Diabetes Care, found that those on the canola ...
Text messages helpful in controlling diabetes
2014-06-14
"Don't forget! Check blood sugar before and after physical activity."
"Use small plates! Portions will look larger and you may feel more satisfied after eating."
"Tick, tock. Take your medication at the same time every day!"
These are just a few of the text messages that participants received as part of the Dulce Digital study conducted by the Scripps Whittier Diabetes Institute, a subsidiary of Scripps Health and one of the nation's leading diabetes research, patient care and education organizations.
Initial results of the Dulce Digital study were presented at ...
Cracks in Pluto's moon could indicate it once had an underground ocean
2014-06-13
If the icy surface of Pluto's giant moon Charon is cracked, analysis of the fractures could reveal if its interior was warm, perhaps warm enough to have maintained a subterranean ocean of liquid water, according to a new NASA-funded study.
Pluto is an extremely distant world, orbiting the sun more than 29 times farther than Earth. With a surface temperature estimated to be about 380 degrees below zero Fahrenheit (around minus 229 degrees Celsius), the environment at Pluto is far too cold to allow liquid water on its surface. Pluto's moons are in the same frigid environment.
Pluto's ...
UH's Thomas Colbert addressing Galveston Bay's Challenges at Rotterdam Biennale
2014-06-13
Coastal communities are often relaxing locales with lush natural attributes. At the same time, they face many challenges from both natural and manmade elements.
Thomas Colbert, professor at the University of Houston's Gerald D. Hines College of Architecture, dedicates his research to discovering ways to protect coastlines and delta regions from severe weather threats and other dangers. This week, he joins a roster of international scholars, designers and architects at the 2014 International Architecture Biennale Rotterdam (IABR) in the Netherlands.
Colbert is among ...
NIH scientists take totally tubular journey through brain cells
2014-06-13
VIDEO:
Researchers watched TAT proteins (green) journey into microtubules (red). TAT proteins are known to label the insides of the tubes. They observed that TAT can move quickly, back and...
Click here for more information.
In a new study, scientists at the National Institutes of Health took a molecular-level journey into microtubules, the hollow cylinders inside brain cells that act as skeletons and internal highways. They watched how a protein called tubulin acetyltransferase ...
NASA experiments recreate aromatic flavors of Titan
2014-06-13
NASA scientists have created a new recipe that captures key flavors of the brownish-orange atmosphere around Saturn's largest moon, Titan.
The recipe is used for lab experiments designed to simulate Titan's chemistry. With this approach, the team was able to classify a previously unidentified material discovered by NASA's Cassini spacecraft in the moon's smoggy haze.
"Now we can say that this material has a strong aromatic character, which helps us understand more about the complex mixture of molecules that makes up Titan's haze," said Melissa Trainer, a planetary scientist ...
'Exquisitely engineered' human vision featured in Optical Engineering
2014-06-13
BELLINGHAM, Washington, USA — A new special section on Human Vision in the current issue of Optical Engineering showcases optics and optical engineering research into new techniques and approaches for the study of human vision and the design of novel imaging systems. Put into practice, these new approaches enable applications such as earlier diagnosis of disease, improved treatment monitoring, and more accurate guidance for treatment and surgery. The journal is published by SPIE, the international society for optics and photonics.
The special section includes 11 papers ...
NASA sees Tropical Storm Nanauk's soaking swan song
2014-06-13
VIDEO:
This TRMM satellite flyby animation shows that Tropical Storm Nanauk contained powerful towering thunderstorms that were reaching heights of up to 16.8 km (10.4 miles) on June 11, 2014....
Click here for more information.
Tropical Storm Nanauk was dissipating in the Arabian Sea on Friday, June 13 as it ran into increasing vertical wind shear, dry air moving into the tropical cyclone and cooler sea surface temperatures. NASA's TRMM satellite observed the soaking rains the ...